# Agora, Inc.: Form 20-F for the period ended Dec 31, 2024

- Company: [Agora, Inc.](/companies/api.md) (CIK 1802883)
- Form: 20-F
- Filed: 2025-04-15
- Accepted by EDGAR: Apr 15, 2025, 07:00 ET
- Period: 2024-12-31
- Accession: 0000950170-25-053943
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1802883/000095017025053943/api-20241231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1802883/000095017025053943/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $133.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $47.8m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $85.4m | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $80.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$53.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $253.0k | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | $258.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | −$42.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.11 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | −$0.11 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 373,122,317 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$14.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $2.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2024-12-31 | $27.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $328.1m | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $699.7m | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $58.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $127.0m | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $46.5m | us-gaap:LongTermDebt |
| Shareholders' equity | at 2024-12-31 | $572.7m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1802883/000095017025053943/api-20241231.htm

Filed Apr 15, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-053943. Last ingested by Listed: Nov 4, 2026, 09:03 ET. No prices; not investment advice.